Kathryn Kyle Biography and Net Worth

Executive Vice President, Chief Legal Officer and Corporate Secretary of Labcorp

Kathryn Kyle has served as Executive Vice President, Chief Legal Officer and Corporate Secretary at Labcorp since January 2026.

Kathryn joined Labcorp in 2003 in the litigation group and has advanced through broader leadership roles in the law department since that time, becoming General Counsel in 2016. Under her leadership, Labcorp has successfully managed major litigation matters and reorganized various legal functions, including intellectual property areas and professional liability claims. Kathryn also successfully introduced legal support technology into core legal functions and provided critical strategic support to the enterprise during crisis events, including the Covid-19 pandemic.

Prior to joining Labcorp, Kathryn was a Senior Corporate attorney with Polaroid Corporation, where she was primarily responsible for employment and labor issues. She previously served as a litigation associate at a western Massachusetts law firm.

Kathryn received her Bachelor’s degree from Smith College and her Juris Doctorate from Emory University School of Law.

What is Kathryn W. Kyle's net worth?: The estimated net worth of Kathryn W. Kyle is at least $1.04 million as of June 8th, 2026. Ms. Kyle owns 3,813 shares of Labcorp stock worth more than $1,044,762 as of June 10th. This net worth evaluation does not reflect any other investments that Ms. Kyle may own. Learn More about Kathryn W. Kyle's net worth.
How do I contact Kathryn W. Kyle?: The corporate mailing address for Ms. Kyle and other Labcorp executives is 358 South Main Street, BURLINGTON NC, 27215. Labcorp can also be reached via phone at (336) 229-1127 and via email at [email protected]. Learn More on Kathryn W. Kyle's contact information.
Has Kathryn W. Kyle been buying or selling shares of Labcorp?: During the last ninety days, Kathryn W. Kyle has sold $201,084.18 of Labcorp stock. Most recently, Kathryn W. Kyle sold 762 shares of the business's stock in a transaction on Monday, June 8th. The shares were sold at an average price of $263.89, for a transaction totalling $201,084.18. Following the completion of the sale, the executive vice president now directly owns 3,813 shares of the company's stock, valued at $1,006,212.57. Learn More on Kathryn W. Kyle's trading history.
Who are Labcorp's active insiders?: Labcorp's insider roster includes Kerrii Anderson (Director), Jean-Luc Belingard (Director), Lance Berberian (EVP), Brian Caveney (EVP), Jonathan DiVincenzo (EVP and President, Central Laboratories and International), Glenn Eisenberg (CFO), Dwight Gilliland (Director), Paul Kirchgraber (CEO), Kathryn Kyle (Executive Vice President, Chief Legal Officer and Corporate Secretary), Jonathan Meltzer (EVP), Peter Neupert (Director), Richelle Parham (Director), Adam Schechter (Chairman, President, and CEO), Mark Schroeder (EVP), Amy Summy (CMO), Sandra van der Vaart (EVP), Peter Wilkinson (CAO), and R. Williams (Director). Learn More on Labcorp's active insiders.
Are insiders buying or selling shares of Labcorp?: During the last year, insiders at the medical research company sold shares 15 times. They sold a total of 51,578 shares worth more than $13,879,786.51. The most recent insider tranaction occured on June, 8th when EVP Kathryn W Kyle sold 762 shares worth more than $201,084.18. Insiders at Labcorp own 0.8% of the company. Learn More about insider trades at Labcorp.
Information on this page was last updated on 6/8/2026.

Kathryn W. Kyle Insider Trading History at Labcorp

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/8/2026	Sell	762	$263.89	$201,084.18	3,813

Kathryn W. Kyle Buying and Selling Activity at Labcorp

Labcorp Company Overview

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Today's Range

Now: $269.03

$270.01

$275.00

50 Day Range

MA: $262.74

$250.30

$275.10

2 Week Range

Now: $269.03

$241.81

$293.72

Volume

230,145 shs

Average Volume

671,027 shs

Market Capitalization

$22.06 billion

P/E Ratio

23.83

Dividend Yield

1.10%

Beta

0.9